title: Soluble interleukin-2 receptor and urinary neopterin concentrations in malignant lymphoma.
abstract: The serum concentrations of soluble interleukin-2 receptors and urine neopterin were studied in 82 patients with malignant lymphomas (25 patients with Hodgkin's disease and 57 patients with non-Hodgkin's lymphoma. Increases in soluble interleukin-2 receptors and in urinary neopterin were significantly correlated with the clinical phase of the disease. The average values in both Hodgkin's disease and non-Hodgkin's lymphoma patients suffering from the disease in its active phase were significantly higher than those of patients in complete remission. Neopterin concentrations (but not soluble interleukin-2 receptor concentrations) were also elevated in clinical stages III-IV of each disease. Urinary neopterin correlated directly and significantly with the erythrocyte sedimentation rate and inversely with haemoglobin. Finally, a longitudinal analysis showed a general tendency for the markers to return to normal values, in accordance with the favourable outcome of therapy; this was more evident for urinary neopterin than for soluble interleukin-2 receptors. These findings seem to confirm that soluble interleukin-2 receptors and especially urinary neopterin can be useful markers for monitoring and prognosis of malignant lymphomas.
authors.affiliation: University of Modena, Italy.
authors.forename: L
authors.initials: L
authors.lastname: Piccinini
authors.forename: S
authors.initials: S
authors.lastname: Zironi
authors.forename: A M
authors.initials: AM
authors.lastname: Cenci
authors.forename: D
authors.initials: D
authors.lastname: Campioli
authors.forename: M
authors.initials: M
authors.lastname: Federico
authors.forename: F
authors.initials: F
authors.lastname: Barbieri
mesh_terms: D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D014408:Biomarkers, Tumor; D001708:Biopterins / Q000031:analogs & derivatives* / Q000652:urine; D002853:Chromatography, Liquid; D004797:Enzyme-Linked Immunosorbent Assay; D005260:Female; D005500:Follow-Up Studies; D006689:Hodgkin Disease / Q000097:blood* / Q000473:pathology / Q000652:urine; D006801:Humans; D008137:Longitudinal Studies; D008228:Lymphoma, Non-Hodgkin / Q000097:blood* / Q000473:pathology / Q000652:urine; D008297:Male; D008875:Middle Aged; D019798:Neopterin; D015375:Receptors, Interleukin-2 / Q000032:analysis*; D012995:Solubility
chemical_list: D014408:Biomarkers, Tumor; D015375:Receptors, Interleukin-2; D001708:Biopterins; D019798:Neopterin